Bayart E et al. |
A major role for mitotic CDC2 kinase inactivation in the establishment of the mitotic DNA damage checkpoint. |
2004 |
Cancer Res. |
pmid:15604258
|
Yang X et al. |
Synergistic activation of functional estrogen receptor (ER)-alpha by DNA methyltransferase and histone deacetylase inhibition in human ER-alpha-negative breast cancer cells. |
2001 |
Cancer Res. |
pmid:11585728
|
Luo W et al. |
Epigenetic regulation of vitamin D 24-hydroxylase/CYP24A1 in human prostate cancer. |
2010 |
Cancer Res. |
pmid:20587525
|
Sasaki Y et al. |
p53 negatively regulates the hepatoma growth factor HDGF. |
2011 |
Cancer Res. |
pmid:22006999
|
Phan D et al. |
Identification of Sp2 as a transcriptional repressor of carcinoembryonic antigen-related cell adhesion molecule 1 in tumorigenesis. |
2004 |
Cancer Res. |
pmid:15126343
|
Wang X et al. |
Correction of the abnormal trafficking of primary myelofibrosis CD34+ cells by treatment with chromatin-modifying agents. |
2009 |
Cancer Res. |
pmid:19752087
|
Wei M et al. |
BRCA1 promoter methylation in sporadic breast cancer is associated with reduced BRCA1 copy number and chromosome 17 aneusomy. |
2005 |
Cancer Res. |
pmid:16322213
|
Mariadason JM et al. |
Genetic reprogramming in pathways of colonic cell maturation induced by short chain fatty acids: comparison with trichostatin A, sulindac, and curcumin and implications for chemoprevention of colon cancer. |
2000 |
Cancer Res. |
pmid:10969808
|
James SY et al. |
Regulation of retinoic acid receptor beta expression by peroxisome proliferator-activated receptor gamma ligands in cancer cells. |
2003 |
Cancer Res. |
pmid:12839938
|
Terui T et al. |
Induction of PIG3 and NOXA through acetylation of p53 at 320 and 373 lysine residues as a mechanism for apoptotic cell death by histone deacetylase inhibitors. |
2003 |
Cancer Res. |
pmid:14695212
|
Shah S et al. |
Targeting pioneering factor and hormone receptor cooperative pathways to suppress tumor progression. |
2012 |
Cancer Res. |
pmid:22258452
|
Sharma D et al. |
Restoration of tamoxifen sensitivity in estrogen receptor-negative breast cancer cells: tamoxifen-bound reactivated ER recruits distinctive corepressor complexes. |
2006 |
Cancer Res. |
pmid:16778215
|
Shi J et al. |
Effects of chromatin-modifying agents on CD34+ cells from patients with idiopathic myelofibrosis. |
2007 |
Cancer Res. |
pmid:17616702
|
Qi H and Ratnam M |
Synergistic induction of folate receptor beta by all-trans retinoic acid and histone deacetylase inhibitors in acute myelogenous leukemia cells: mechanism and utility in enhancing selective growth inhibition by antifolates. |
2006 |
Cancer Res. |
pmid:16740727
|
Yoshida M et al. |
Effects of trichostatins on differentiation of murine erythroleukemia cells. |
1987 |
Cancer Res. |
pmid:2439196
|
Singal R et al. |
Cytosine methylation represses glutathione S-transferase P1 (GSTP1) gene expression in human prostate cancer cells. |
2001 |
Cancer Res. |
pmid:11406558
|
Brest P et al. |
Histone deacetylase inhibitors promote the tumoricidal effect of HAMLET. |
2007 |
Cancer Res. |
pmid:18056459
|
Maecker HL et al. |
p53 promotes selection for Fas-mediated apoptotic resistance. |
2000 |
Cancer Res. |
pmid:10969818
|
Su GH et al. |
A novel histone deacetylase inhibitor identified by high-throughput transcriptional screening of a compound library. |
2000 |
Cancer Res. |
pmid:10866300
|
Blagosklonny MV et al. |
Depletion of mutant p53 and cytotoxicity of histone deacetylase inhibitors. |
2005 |
Cancer Res. |
pmid:16103091
|
Lin F et al. |
Unique anti-activator protein-1 activity of retinoic acid receptor beta. |
2000 |
Cancer Res. |
pmid:10866321
|
Sirchia SM et al. |
Endogenous reactivation of the RARbeta2 tumor suppressor gene epigenetically silenced in breast cancer. |
2002 |
Cancer Res. |
pmid:11980632
|
Hsu PY et al. |
Xenoestrogen-induced epigenetic repression of microRNA-9-3 in breast epithelial cells. |
2009 |
Cancer Res. |
pmid:19549897
|
Heller G et al. |
Genome-wide transcriptional response to 5-aza-2'-deoxycytidine and trichostatin a in multiple myeloma cells. |
2008 |
Cancer Res. |
pmid:18172295
|
Shin JY et al. |
Mechanism for inactivation of the KIP family cyclin-dependent kinase inhibitor genes in gastric cancer cells. |
2000 |
Cancer Res. |
pmid:10667572
|
Kretzner L et al. |
Combining histone deacetylase inhibitor vorinostat with aurora kinase inhibitors enhances lymphoma cell killing with repression of c-Myc, hTERT, and microRNA levels. |
2011 |
Cancer Res. |
pmid:21502403
|
Saunders N et al. |
Histone deacetylase inhibitors as potential anti-skin cancer agents. |
1999 |
Cancer Res. |
pmid:9927053
|
Ramsey MR et al. |
Physical association of HDAC1 and HDAC2 with p63 mediates transcriptional repression and tumor maintenance in squamous cell carcinoma. |
2011 |
Cancer Res. |
pmid:21527555
|
Medina V et al. |
Induction of caspase-3 protease activity and apoptosis by butyrate and trichostatin A (inhibitors of histone deacetylase): dependence on protein synthesis and synergy with a mitochondrial/cytochrome c-dependent pathway. |
1997 |
Cancer Res. |
pmid:9288776
|
Harada K et al. |
Deregulation of caspase 8 and 10 expression in pediatric tumors and cell lines. |
2002 |
Cancer Res. |
pmid:12384554
|
Wilson AJ et al. |
Novel detection and differential utilization of a c-myc transcriptional block in colon cancer chemoprevention. |
2002 |
Cancer Res. |
pmid:12414619
|
Ho WC et al. |
Nuclear factor-kappaB induced by doxorubicin is deficient in phosphorylation and acetylation and represses nuclear factor-kappaB-dependent transcription in cancer cells. |
2005 |
Cancer Res. |
pmid:15899819
|
Tran T et al. |
Enhancement of folate receptor alpha expression in tumor cells through the glucocorticoid receptor: a promising means to improved tumor detection and targeting. |
2005 |
Cancer Res. |
pmid:15899836
|
Kim MS et al. |
Inhibition of histone deacetylase increases cytotoxicity to anticancer drugs targeting DNA. |
2003 |
Cancer Res. |
pmid:14612526
|
Majid S et al. |
Regulation of minichromosome maintenance gene family by microRNA-1296 and genistein in prostate cancer. |
2010 |
Cancer Res. |
pmid:20332239
|
Liu LT et al. |
Histone deacetylase inhibitor up-regulates RECK to inhibit MMP-2 activation and cancer cell invasion. |
2003 |
Cancer Res. |
pmid:12810630
|
Allison SJ and Milner J |
Loss of p53 has site-specific effects on histone H3 modification, including serine 10 phosphorylation important for maintenance of ploidy. |
2003 |
Cancer Res. |
pmid:14583461
|
Lin YC et al. |
Statins increase p21 through inhibition of histone deacetylase activity and release of promoter-associated HDAC1/2. |
2008 |
Cancer Res. |
pmid:18381445
|
Wang J et al. |
Inhibitors of histone deacetylase relieve ETO-mediated repression and induce differentiation of AML1-ETO leukemia cells. |
1999 |
Cancer Res. |
pmid:10383127
|
Myzak MC et al. |
A novel mechanism of chemoprotection by sulforaphane: inhibition of histone deacetylase. |
2004 |
Cancer Res. |
pmid:15313918
|
Kim TY et al. |
Epigenomic profiling reveals novel and frequent targets of aberrant DNA methylation-mediated silencing in malignant glioma. |
2006 |
Cancer Res. |
pmid:16885346
|
Ferrara FF et al. |
Histone deacetylase-targeted treatment restores retinoic acid signaling and differentiation in acute myeloid leukemia. |
2001 |
Cancer Res. |
pmid:11196162
|
Zhao S et al. |
Requirement of a specific Sp1 site for histone deacetylase-mediated repression of transforming growth factor beta Type II receptor expression in human pancreatic cancer cells. |
2003 |
Cancer Res. |
pmid:12750289
|
Bai J et al. |
Predominant Bcl-XL knockdown disables antiapoptotic mechanisms: tumor necrosis factor-related apoptosis-inducing ligand-based triple chemotherapy overcomes chemoresistance in pancreatic cancer cells in vitro. |
2005 |
Cancer Res. |
pmid:15781649
|
Yang X et al. |
Transcriptional activation of estrogen receptor alpha in human breast cancer cells by histone deacetylase inhibition. |
2000 |
Cancer Res. |
pmid:11156387
|
Rahmani M et al. |
Coadministration of histone deacetylase inhibitors and perifosine synergistically induces apoptosis in human leukemia cells through Akt and ERK1/2 inactivation and the generation of ceramide and reactive oxygen species. |
2005 |
Cancer Res. |
pmid:15781658
|
Stiehl DP et al. |
Histone deacetylase inhibitors synergize p300 autoacetylation that regulates its transactivation activity and complex formation. |
2007 |
Cancer Res. |
pmid:17332356
|
Kim M et al. |
LRRC3B, encoding a leucine-rich repeat-containing protein, is a putative tumor suppressor gene in gastric cancer. |
2008 |
Cancer Res. |
pmid:18757430
|
Mori T et al. |
Epigenetic up-regulation of C-C chemokine receptor 7 and C-X-C chemokine receptor 4 expression in melanoma cells. |
2005 |
Cancer Res. |
pmid:15753377
|
Zhu WG et al. |
DNA methyltransferase inhibition enhances apoptosis induced by histone deacetylase inhibitors. |
2001 |
Cancer Res. |
pmid:11245429
|